258 related articles for article (PubMed ID: 31620025)
1. Targeting the Glucocorticoid Receptors During Alcohol Withdrawal to Reduce Protracted Neurocognitive Disorders.
Béracochéa D; Mons N; David V
Front Psychiatry; 2019; 10():580. PubMed ID: 31620025
[TBL] [Abstract][Full Text] [Related]
2. Preventive Effects of Baclofen but Not Diazepam on Hippocampal Memory and Glucocorticoid Alterations After Prolonged Alcohol Withdrawal in Mice.
Nadia H; Fabienne M; Pierard C; Nicole M; Daniel B
Front Psychiatry; 2022; 13():799225. PubMed ID: 35686185
[TBL] [Abstract][Full Text] [Related]
3. Baclofen but Not Diazepam Alleviates Alcohol-Seeking Behavior and Hypothalamic-Pituitary-Adrenal Axis Dysfunction in Stressed Withdrawn Mice.
Rabat Y; Henkous N; Corio M; Nogues X; Beracochea D
Front Psychiatry; 2019; 10():238. PubMed ID: 31105600
[TBL] [Abstract][Full Text] [Related]
4. Repeated diazepam administration reversed working memory impairments and glucocorticoid alterations in the prefrontal cortex after short but not long alcohol-withdrawal periods.
Dominguez G; Henkous N; Pierard C; Belzung C; Mons N; Beracochea D
Cogn Affect Behav Neurosci; 2018 Aug; 18(4):665-679. PubMed ID: 29713956
[TBL] [Abstract][Full Text] [Related]
5. Selective increases in regional brain glucocorticoid: a novel effect of chronic alcohol.
Little HJ; Croft AP; O'Callaghan MJ; Brooks SP; Wang G; Shaw SG
Neuroscience; 2008 Oct; 156(4):1017-27. PubMed ID: 18801418
[TBL] [Abstract][Full Text] [Related]
6. Alcohol withdrawal induces long-lasting spatial working memory impairments: relationship with changes in corticosterone response in the prefrontal cortex.
Dominguez G; Belzung C; Pierard C; David V; Henkous N; Decorte L; Mons N; Beracochea D
Addict Biol; 2017 Jul; 22(4):898-910. PubMed ID: 26860616
[TBL] [Abstract][Full Text] [Related]
7. Abstinence from prolonged ethanol exposure affects plasma corticosterone, glucocorticoid receptor signaling and stress-related behaviors.
Somkuwar SS; Vendruscolo LF; Fannon MJ; Schmeichel BE; Nguyen TB; Guevara J; Sidhu H; Contet C; Zorrilla EP; Mandyam CD
Psychoneuroendocrinology; 2017 Oct; 84():17-31. PubMed ID: 28647675
[TBL] [Abstract][Full Text] [Related]
8. GABA systems, benzodiazepines, and substance dependence.
Malcolm RJ
J Clin Psychiatry; 2003; 64 Suppl 3():36-40. PubMed ID: 12662132
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and side effects of baclofen and the novel GABA
Vengeliene V; Takahashi TT; Dravolina OA; Belozertseva I; Zvartau E; Bespalov AY; Spanagel R
Psychopharmacology (Berl); 2018 Jul; 235(7):1955-1965. PubMed ID: 29651507
[TBL] [Abstract][Full Text] [Related]
10. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons.
Obrietan K; van den Pol AN
J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics.
Ozsoy S; Esel E; Turan T; Kula M
Alcohol; 2007 Dec; 41(8):551-6. PubMed ID: 18047908
[TBL] [Abstract][Full Text] [Related]
12. Baclofen: a new drug for the treatment of alcohol dependence.
Addolorato G; Leggio L; Agabio R; Colombo G; Gasbarrini G
Int J Clin Pract; 2006 Aug; 60(8):1003-8. PubMed ID: 16893442
[TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
Koek W; Carter LP; Wu H; Coop A; France CP
Behav Pharmacol; 2006 May; 17(3):239-47. PubMed ID: 16572002
[TBL] [Abstract][Full Text] [Related]
14. The development of medications for alcohol-use disorders targeting the GABAB receptor system.
Agabio R; Maccioni P; Carai MA; Gessa GL; Froestl W; Colombo G
Recent Pat CNS Drug Discov; 2012 Aug; 7(2):113-28. PubMed ID: 22574677
[TBL] [Abstract][Full Text] [Related]
15. Role of GABA receptor subtypes in inhibition of primate spinothalamic tract neurons: difference between spinal and periaqueductal gray inhibition.
Lin Q; Peng YB; Willis WD
J Neurophysiol; 1996 Jan; 75(1):109-23. PubMed ID: 8822545
[TBL] [Abstract][Full Text] [Related]
16. Characterization of bicuculline/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists.
Woodward RM; Polenzani L; Miledi R
Mol Pharmacol; 1993 Apr; 43(4):609-25. PubMed ID: 8386310
[TBL] [Abstract][Full Text] [Related]
17. Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment.
Krystal JH; Staley J; Mason G; Petrakis IL; Kaufman J; Harris RA; Gelernter J; Lappalainen J
Arch Gen Psychiatry; 2006 Sep; 63(9):957-68. PubMed ID: 16952998
[TBL] [Abstract][Full Text] [Related]
18. [Antiabstinent action of fenibut and baclofen on a model of abstinence induced by the benzodiazepine receptor antagonist CGS 8216 in rats receiving diazepam].
Zharkovskiĭ AM; Zharkovskaia TA
Biull Eksp Biol Med; 1987 Jun; 103(6):677-8. PubMed ID: 3036269
[TBL] [Abstract][Full Text] [Related]
19. Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase.
Brooks SP; Croft AP; Norman G; Shaw SG; Little HJ
Neuroscience; 2008 Nov; 157(2):376-84. PubMed ID: 18835336
[TBL] [Abstract][Full Text] [Related]
20. [GABAB receptor as therapeutic target for drug addiction: from baclofen to positive allosteric modulators].
Agabio R; Colombo G
Psychiatr Pol; 2015; 49(2):215-23. PubMed ID: 26093587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
